| scholarly article | Q13442814 |
| P2093 | author name string | G. D. Lowe | |
| F. G. Dunn | |||
| A. Rumley | |||
| M. J. Metcalfe | |||
| G. Y. Lip | |||
| P2860 | cites work | von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death | Q33611676 |
| Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study | Q34173732 | ||
| Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements | Q39605651 | ||
| Intracardiac thrombi and systemic embolization | Q39731258 | ||
| Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 | ||
| Genetic and cultural inheritance of plasma fibrinogen concentration | Q47391741 | ||
| Platelet function tests in thrombotic cerebrovascular disorders | Q48786132 | ||
| Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial | Q68495699 | ||
| Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems | Q69903517 | ||
| Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis | Q70448921 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| A study of hemostasis in ischemic cerebrovascular disease. I. Abnormalities in factor VIII and antithrombin | Q71616822 | ||
| Haemostatic function and cardiovascular death: early results of a prospective study | Q72423400 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | (RS)-warfarin | Q407431 |
| coronary artery disease | Q844935 | ||
| left ventricular dysfunction | Q11755424 | ||
| ventricular dysfunction | Q54911334 | ||
| P304 | page(s) | 453-458 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms | |
| P478 | volume | 76 |
| Q85049938 | A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation |
| Q35091945 | Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention |
| Q34027433 | Cardiomyopathy and embolization: risks and benefits of anticoagulation in sinus rhythm |
| Q43803000 | Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm |
| Q53358752 | Effects of warfarin on markers of hypercoagulability in patients with heart failure. |
| Q73614931 | Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus? |
| Q55008079 | Heart Failure as a Risk Factor for Stroke. |
| Q57073286 | Hemostatic state and atrial fibrillation (The Framingham Offspring Study) |
| Q38646824 | Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy |
| Q36666482 | Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review |
| Q59100784 | Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis |
| Q38438066 | Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication |
| Q74197646 | Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples |
| Q34027114 | Pulmonary embolism: investigation of the clinically assessed intermediate risk subgroup |
| Q50199930 | The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants |
| Q74189342 | Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients |
| Q74601166 | [Thrombogenic and endothelial damage markers in patients with ischemic systolic impairment] |
| Q36825948 | von Willebrand factor and its relevance to cardiovascular disorders |
| Q73763745 | von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair |
Search more.